2012-10-06 19:07:17 - New Pharmaceuticals market report from Global Markets Direct: "Viral Infections - Pipeline Review, H2 2012"

Global Markets Direct's, 'Viral Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Viral Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Viral Infections. Viral Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468429_viral_infections_pipeline_review_h2_2 ..


Note*: Certain sections in the report may be removed or altered based on the availability and

relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Viral Infections.
* A review of the Viral Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Viral Infections pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Viral Infections.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Viral Infections pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Viral Infections Overview
Therapeutics Development
An Overview of Pipeline Products for Viral Infections
Viral Infections Therapeutics under Development by Companies
Viral Infections Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Viral Infections Therapeutics - Products under Development by Companies
Viral Infections Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Viral Infections Therapeutics Development
Bristol-Myers Squibb Company
Vical Incorporated
United Therapeutics Corporation
Shionogi & Co., Ltd.
Sanofi-Aventis
GlaxoSmithKline plc
Nektar Therapeutics
Inovio Biomedical Corporation
Bavarian Nordic A/S
MedImmune LLC
Gilead Sciences, Inc.
VIRxSYS Corporation
Merck & Co., Inc.
United Biomedical, Inc.
Lentigen Corporation
Myriad Genetics, Inc.
Sangamo BioSciences, Inc.
Cytokine PharmaSciences, Inc.
Generex Biotechnology Corporation
Takeda Pharmaceutical Company Limited
Symphogen A/S
Nanotherapeutics, Inc.
Panacos Pharmaceuticals, Inc.
Biotron Limited
Nabi Biopharmaceuticals
Aphios Corporation
Achillion Pharmaceuticals, Inc.
Esteve Group
Human Genome Sciences, Inc.
SuperGen, Inc.
Hadasit Medical Research Services & Development Ltd
Starpharma Holdings Limited
Immuron Limited
TapImmune Inc.
Samaritan Pharmaceuticals, Inc.
Panacea Biotec Limited
BioAlliance Pharma SA
Clavis Pharma ASA
Transgene Biotek Ltd
Narhex Life Sciences Limited
Paloma Pharmaceuticals, Inc.
Antigen Express, Inc.
Digna Biotech, S.L.
Functional Genetics, Inc.
Chipscreen Biosciences Ltd
Nutri Pharma ASA
LigoCyte Pharmaceuticals, Inc.
Evolva SA
Pharmaplaz Ltd.
BioMAS Ltd.
Vironova AB
ViroStatics, srl
Argos Therapeutics, Inc.
Cytheris SA
Altor BioScience Corporation
PX'Therapeutics SA
Telormedix SA
Osel Inc.
Heat Biologics, Inc.
MacroGenics, Inc.
AiCuris GmbH & Co. KG
GeneScience Pharmaceuticals Co., Ltd.
AlphaVax, Inc.
PTC Therapeutics, Inc.
Amplyx Pharmaceuticals, Inc.
EpiVax, Inc.
Kineta, Inc.
Indus Biotech Private Limited
Locus Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc.
Chimerix, Inc.
Theraclone Sciences, Inc.
Frontier Biotechnologies, Inc.
Biotica Technology Ltd
Polaris Group
ImQuest Life Sciences
FunZyme BioTechnologies S.A.
Viral Infections - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
cobicistat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
dolutegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Flavimun - Drug Profile
Product Description

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468429&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.